Product NDC: | 0781-2865 |
Proprietary Name: | Ranitidine Hydrochloride |
Non Proprietary Name: | Ranitidine Hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; Ranitidine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-2865 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074655 |
Marketing Category: | ANDA |
Start Marketing Date: | 19971022 |
Package NDC: | 0781-2865-31 |
Package Description: | 30 CAPSULE in 1 BOTTLE (0781-2865-31) |
NDC Code | 0781-2865-31 |
Proprietary Name | Ranitidine Hydrochloride |
Package Description | 30 CAPSULE in 1 BOTTLE (0781-2865-31) |
Product NDC | 0781-2865 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19971022 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |